Cytokinetics dcf value
WebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by … WebBased on 13 Wall Street analysts offering 12 month price targets for Cytokinetics in the last 3 months. The average price target is $58.50 with a high forecast of $80.00 and a low forecast of $42.00. The average price target represents a 66.24% change from the last price of $35.19. Best Analysts Covering Cytokinetics Most Accurate Analysts
Cytokinetics dcf value
Did you know?
WebApr 7, 2024 · To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios. Stocks with a Value Score from 81-100 are considered deep value, those with a score between 61-80 are value and so on. Cytokinetics, Inc. does not have a meaningful Value Score. WebDec 30, 2024 · Summary DCF Valuation Relative Valuation Wall St Estimates Profitability …
WebFeb 23, 2024 · In-depth view into Cytokinetics Inc (NASDAQ:CYTK) intrinsic valuation including the DCF Valuation, Relative Valuation, its profitability and solvency analysis, and more. WebJul 19, 2024 · Shares in Cytokinetics surged after it reported positive mid-stage results for CK-274, a drug for hypertrophic cardiomyopathy (HCM) that could tread on the toes of Bristol-Myers Squibb's ...
WebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential … WebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity. Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate
WebMar 31, 2024 · On Friday 03/03/2024 the closing price of the Cytokinetics Inc share was $41.95 on NAS. Compared to the opening price on Friday 03/03/2024 on NAS of $39.73, this is a gain of 5.29%. Cytokinetics ...
WebValuation Bulls & Bears DCF The closing share price for Cytokinetics (CYTK) stock was … immersion heater backerWebFeb 15, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential... immersion heater backnutWebOct 25, 2024 · Cytokinetics expects that it will end 2024 with more than $800 million in cash. This, despite the fact that it expects that its operating expenses for all of 2024 to end up being in the range of ... immersion heater best way to use itWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential... immersion heater cable size ukimmersion heater bird bathWebFeb 17, 2024 · Cytokinetics stock was originally listed at a price of $97.56 in Apr 30, … immersion heater and rheostat circuitWebCYTK: Raising target price to $38.00CYTOKINETICS INC has an Investment Rating of … immersion heater cable clamp